Overexpression of UHRF1 accompanied with downregulation of tumor suppressor genes and increased expression of EZH2 (H3K27 methyltransferase) in prostate cancer cells contributed to the poor clinical prognosis and lethal progression disease. This evidence concerns the gene UHRF1 and Familial prostate cancer.